Octavian Ioachimescu, MD, PhD, MBA

Publications

• Accuracy of residual respiratory event detection by CPAPs: a meta-analysis

  (Iftikhar IH, BaHammam A, Jahrami H, Ioachimescu O.) Sleep and Breathing. October 2023;27(5):1759-1768 SCOPUS ID: 2-s2.0-85147034984 10/01/2023

• Site readiness practices for clinical trials - Considerations for CTSA hubs

  (Viera L, James L, Shekhar A, Ioachimescu OC, Buse JB.) Journal of Clinical and Translational Science. 29 June 2023;7(1) SCOPUS ID: 2-s2.0-85164397947 06/29/2023

• Glucocorticoid therapy in respiratory illness: bench to bedside.

  (Amratia DA, Viola H, Ioachimescu OC.) J Investig Med. 2022 Dec;70(8):1662-1680 PMID: 35764344 PMCID: PMC9726965 SCOPUS ID: 2-s2.0-85134601973 06/29/2022

• From Seven Sweethearts to Life Begins at Eight Thirty: A Journey From Life's Simple 7 to Life's Essential 8 and Beyond.

  (Ioachimescu OC.) J Am Heart Assoc. 2022 Nov;11(21):e027658 PMID: 36259614 PMCID: PMC9673622 SCOPUS ID: 2-s2.0-85141004063 10/20/2022

• Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.

  (Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, Davis-Karim A, Umberger R, Anzueto A, Sriram P, Lan C, Restrepo MI, Guardiola JJ, Buck T, Johnson DP, Suffredini A, Bell WA, Lin J, Zhao L, Uyeda L, Nielsen L, Huang GD, ESCAPe Study Group.) Intensive Care Med. 2022 Aug;48(8):1009-1023 PMID: 35723686 PMCID: PMC9208259 SCOPUS ID: 2-s2.0-85129893494 06/21/2022

• Chronic Obstructive Pulmonary Disease-Obstructive Sleep Apnea Overlap: More Than a Casual Acquaintance.

  (Ioachimescu OC, McNicholas WT.) Am J Respir Crit Care Med. 2022 Jul 15;206(2):139-141 PMID: 35549667 PMCID: PMC9887423 SCOPUS ID: 2-s2.0-85134178453 05/14/2022

• An extraordinary story of discovery: an interview with Doctor Max D Cooper.

  (Ioachimescu OC, Cooper MD.) J Investig Med. 2022 Jul 12;70(7):1461-5 PMID: 35820715 PMCID: PMC9554051 SCOPUS ID: 2-s2.0-85134564567 07/13/2022

• Area under the expiratory flow-volume curve: normative values in the National Health and Nutrition Survey (NHANES) study.

  (Ioachimescu OC, McCarthy K, Stoller JK.) J Investig Med. 2022 Jun;70(5):1247-1257 PMID: 35190486 PMCID: PMC9240334 SCOPUS ID: 2-s2.0-85133100654 02/23/2022

• On PAT, Patterns and Paths.

  (Ioachimescu OC.) Sleep. 2022 May 12;45(5) PMID: 35554587 SCOPUS ID: 2-s2.0-85130014516 05/14/2022

• Sphinganine is associated with 24-h MAP in the non-sleepy with OSA.

  (Pak VM, Russell K, Shi Z, Zhang Q, Cox J, Uppal K, Yu T, Hertzberg V, Liu K, Ioachimescu OC, Collop N, Bliwise DL, Kutner NG, Rogers A, Dunbar SB.) Metabolomics. 2022 Apr 07;18(4):23 PMID: 35391564 SCOPUS ID: 2-s2.0-85128085690 04/09/2022

• A meta-analysis of diagnostic test performance of peripheral arterial tonometry studies.

  (Iftikhar IH, Finch CE, Shah AS, Augunstein CA, Ioachimescu OC.) J Clin Sleep Med. 2022 Apr 01;18(4):1093-1102 PMID: 34879903 PMCID: PMC8974372 SCOPUS ID: 2-s2.0-85128159936 12/10/2021

• Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.

  (Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW, COV-BARRIER Study Group.) Lancet Respir Med. 2021 Dec;9(12):1407-1418 PMID: 34480861 PMCID: PMC8409066 SCOPUS ID: 2-s2.0-85120158583 09/05/2021